The University of Michigan Preliminary Consumer Sentiment for December came in at 91.8, a slight increase from the 91.3 November Final reading. Investing.com had forecast an even 92.0. Surveys of Consumers chief economist, Richard Curtin makes the following comments: While the preliminary
December 11, 2015
Expectations of a Santa Rally went further on hold this week. Our benchmark S&P 500 plunged at the open, triggered to some extent by a savage selloff in oil (WTIC is down -14.5% month-to-date). The 500 proceeded to slide deeper
Abbott (ABT) is a dividend aristocrat with excellent long-term growth potential. The company maintains a diversified mix of healthcare products that are sold around the world. Many of these products are recession-resistant and will enjoy more demand as consumer wealth
The Pope has inaugurated a new holy year of mercy by opening the splendid doors of a Vatican chapel. He intoned (but not in Hebrew) the words of Psalm 118: Open for me the Gates of Righteousness. In Hebrew the
Overvalued No Matter How You Look Currently, stocks are extremely overvalued by multiple methods. The first way is by looking at Cyclically Adjusted P/E Ratios commonly known as CAPE, Shiller P/E, or P/E 10 ratio. The second is by looking at median
We tend to think of economic crises as relatively rare, isolated events like the Great Depression or the 2008 meltdown. But in truth, they are pretty common. They’ve been happening for thousands of years, and few generations escape them. This
Asia managed a mixed session torn between the falling oil price and the Dow’s rally. Europe was very sure what should happen when oil was hit again this morning. When WTI and Brent fell another 1.5% on the back of
Over the past week, my market health indicators mostly fell, but none of them fell enough to change any portfolio allocations. The market trend category is the closest to going negative, but still hanging on. One thing of note this
You can now get Walmart (NYSE:WMT) at a Walmart price, and its a bargain, like I’ve said before. Consider this. The market cap of $191 billion is less than 40% of the current year’s estimated sales of $500 billion. Compare the current Price/Earnings
The Wyden-Grassley report has ruffled some feathers in the pharmaceutical industry. The 18 month investigation determined that Gilead GILD priced Sovaldi ($1,000 pill per day) to maximize revenue; R&D costs or the multi-billion acquisition of Pharmasset may not have factored
